FoxBio Company

FoxBio is a Company that will develop Antoxerene’s collection of small molecules that target senescent cells.

Industry: Biopharma, Biotechnology, Life Science
Technology: Geroscience
Investors Number: 2
Headquarters: Lafayette, Louisiana, United States
Number Of Exists: Venture - Series Unknown
Investor Type: Company
Total Funding: 10000000
Founded Date: 2018
Last Funding Type: Venture - Series Unknown
Last Funding Date: 2018